Research of relationship between gene polymorphisms of methylenetetrahydrofolate reductase enzyme and lung cancer

Chinese Journal of Cancer Prevention and Treatment

Volumn 14, Issue 12, 2007, Pages 888-891

  Jin, Chuan ^a   Zhang, Yong Hui ^a   Peng, Mei Fang ^a   Li, Wei Dong ^a   Ma, Lei ^a   Chen, Wen Sheng ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

10 methylenetrahydrofolate reductase; Genes; Lung neoplasms; N5

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); RESTRICTION ENDONUCLEASE;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; STATISTICAL SIGNIFICANCE;

EID: 77953425103     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Weisberg I S, Jacques P F, Selhub J, et al. The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTH-FR): in vitro expression and association with homocysteine[J]. Atherosclerosis, 2001,156(2):409-415.
2. Rampersaud G C, Kauwell G P, Hutson A D, et al. Genomic DNA methylation decrease in response to moderate folate depletion in elderly women[J]. Am J Clin Nutr, 2000,72(10):998-1003.
3. Boushey C J, Beresford S A, Omenn G S, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes[J]. JAMA, 1995,274(13):1049-1057.
4. Brattstrom L, Wilcken D E, Ohrvik J, et al. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis[J]. Circulation, 1998,98(23):2520-2526.
5. Chen J, Giovannucci E, Hankinson S E, et al. A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma [J] Carcinogenesis, 1998,19(12):2129-2132.
6. Slattery M L, Potter J D, Samowitz W, et al. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer[J]. Cancer Epidemiol Biomarkers Prev, 1999,8(6):513-518.
7. Curtin K, Bigler J, Slattery M L, et al. MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer[J]. Cancer Epidemiol Biomarkers Prev, 2004,13(2): 285-292.
8. Song C, Xing D, Tan W, et al. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population[J]. Cancer Res, 2001,61 (8):3272-3285.
9. Chinese source.
10. Chinese source.
11. Heijmans B T, Boer J M, Suchiman H E, et al. A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer [J]. Cancer Res, 2003,15(5):1249-1253.
12. Shen H, Spitz M R, Wang L E, et al. Polyrnorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer a case-control study[J]. Cancer Epidemiol Biomarkers Prev, 2001, 10 (4):397-401.
13. Paz M F, Avila S, Fraga M F, et al. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors[J]. Cancer Res, 2002,62(8):4519-4524.
14. Siemianowicz K, Gminski J, Garczorz W, et al. Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms in patients with small cell and non-small cell lung cancer[J]. Oncol Rep, 2003,10(5):1341-1344.